Safety of high-dose rate (HDR) brachytherapy for patients with prostate cancer and history of prior chemoradiation for rectal cancer: A case series

A history of prior pelvic radiation therapy (RT) for rectal cancer is a relative contraindication for definitive RT for prostate cancer. High-dose-rate (HDR) brachytherapy can significantly limit the dose to surrounding tissues compared to external beam RT. However, there is limited data surrounding its safety in patients with prior pelvic RT.

Source: Brachytherapy - December 29, 2023 Category: Cancer & Oncology Authors: Horatio Thomas, Jie Jane Chen, Hasan Abdul-Baki, Ali Sabbagh, Haitham Shaheen, Oi Wai Chau, Nauman Malik, Alan Ayoub, Comron Hassanzadeh, I-Chow Hsu, Osama Mohamad Tags: Original Article Source Type: research